Invention Grant
- Patent Title: 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
-
Application No.: US12976122Application Date: 2010-12-22
-
Publication No.: US08394815B2Publication Date: 2013-03-12
- Inventor: Raed H. Al-Qawasmeh , Aiping H. Young , Mario Huesca , Yoon S. Lee
- Applicant: Raed H. Al-Qawasmeh , Aiping H. Young , Mario Huesca , Yoon S. Lee
- Applicant Address: CA Toronto
- Assignee: Lorus Therapeutics Inc.
- Current Assignee: Lorus Therapeutics Inc.
- Current Assignee Address: CA Toronto
- Agency: McAndrews, Held & Malloy Ltd.
- Priority: CA2398765 20020819
- Main IPC: C07D471/12
- IPC: C07D471/12 ; A61K31/435 ; A61P31/04
Abstract:
The present invention provides therapeutically effective 2,4,5-trisubstituted imidazole compounds, methods of preparing the same, and compositions comprising the compounds alone or in combination with other agents. The present invention further provides for the use of the compounds as anti-microbial agents. The anti-microbial properties of the compounds include anti-bacterial and/or anti-fungal activity.
Public/Granted literature
- US20110152337A1 2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS Public/Granted day:2011-06-23
Information query
